Kuwait Intravenous Solutions Market Size & Outlook
Kuwait intravenous solutions market, 2018-2030 (US$M)
Related Markets
Kuwait intravenous solutions market highlights
- The Kuwait intravenous solutions market generated a revenue of USD 46.6 million in 2023 and is expected to reach USD 64.2 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, total parenteral nutrition was the largest revenue generating product in 2023.
- Total Parenteral Nutrition is the most lucrative product segment registering the fastest growth during the forecast period.
Intravenous solutions market data book summary
| Market revenue in 2023 | USD 46.6 million |
| Market revenue in 2030 | USD 64.2 million |
| Growth rate | 4.7% (CAGR from 2023 to 2030) |
| Largest segment | Total parenteral nutrition |
| Fastest growing segment | Total Parenteral Nutrition |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Total Parenteral Nutrition, Peripheral Parenteral Nutrition |
| Key market players worldwide | Fresenius SE & Co KGaA, Fresenius Kabi, Pfizer Inc, Otsuka Pharmaceutical, Baxter International Inc, B. Braun, JW Life Sciences, CSL Ltd |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.4% of the global intravenous solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa intravenous solutions market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 251.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Solutions Market Scope
Intravenous Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait intravenous solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous solutions market will help companies and investors design strategic landscapes.
Total parenteral nutrition was the largest segment with a revenue share of 66.09% in 2023. Horizon Databook has segmented the Kuwait intravenous solutions market based on total parenteral nutrition, peripheral parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait’s growing aging population contributes to market growth. In addition, the country is following National Development Plan, which aims to upgrade the country’s existing healthcare infrastructure. According to International Trade Administration, 80% of healthcare spending is under public healthcare.
Moreover, Kuwait’s Ministry of Health has major stakes in the healthcare sector, with significant involvement in purchasing decisions of pharmaceuticals and medical equipment. In addition, the government operates 28 general and specialized hospitals.
Furthermore, the Ministry of Health and the Ministry of Public Works announced to replace and expand nine operating hospitals in the upcoming years. By the end of this strategic move, an estimated 5,400 beds and 500 outpatient clinics will be added to the country’s healthcare setup.
Reasons to subscribe to Kuwait intravenous solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait intravenous solutions market databook
-
Our clientele includes a mix of intravenous solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait intravenous solutions market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait intravenous solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait intravenous solutions market size, by product, 2018-2030 (US$M)
Kuwait Intravenous Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
